Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. (Q33993644)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Kakuda TN

series ordinal

1

1 reference

30 July 2017

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

685-708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4 cells per cubic millimeter. North American HIV Working Party

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinica

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV 3TC) combination therapy in patients previously treated with ZDV ddC

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Lipodystrophy in patients naive to HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Mitochondrial toxicity of antiviral drugs

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

1 reference

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Oxidative phosphorylation at the fin de siècle

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Mitochondrial diseases in man and mouse

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Mitochondrial disorders: clinical and genetic features

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Mitochondrial DNA and disease

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Cellular phosphorylation of anti-HIV nucleosides. Role of nucleoside diphosphate kinase

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

DNA Polymerases versus HIV Reverse Transcriptase in AIDS Therapy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

The 5'-triphosphates of 3'-azido-3'-deoxythymidine and 2', 3'-dideoxynucleosides inhibit DNA polymerase gamma by different mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Efficient Incorporation of Anti-HIV Deoxynucleotides by Recombinant Yeast Mitochondrial DNA Polymerase

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Mechanisms of toxicity of 3'-azido-3'-deoxythymidine. Its interaction with adenylate kinase.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

AZT causes tissue-specific inhibition of mitochondrial bioenergetic function

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Lack of mitochondrial toxicity in CEM cells treated with carbovir

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

AZT incorporation into mitochondria: study in a human myeloid cell line

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

The Friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3'-azido-3'-dideoxythymidine and dideoxynucleoside inhibition of mtDNA replication

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Effect of 2′,3′-dideoxycytidine on oxidative phosphorylation in the PC 12 cell, a neuronal model

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Zidovudine and dideoxynucleosides deplete wild-type mitochondrial DNA levels and increase deleted mitochondrial DNA levels in cultured Kearns-Sayre syndrome fibroblasts

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Nuclear and mitochondrial changes of co-cultivated spinal cord, spinal ganglia and muscle fibers following treatment with various doses of zidovudine

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Disruption of mitochondrial energetics and DNA synthesis by the anti-AIDS drug dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2',3'-dideoxycytidine

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

The universality of bioenergetic disease and amelioration with redox therapy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Hepatic Morphological alterations induced by zidovudine (ZDV) in an experimental model

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Hearing loss and antiretroviral therapy in patients infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Acute pancreatitis in human immunodeficiency virus-infected patients: a review

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Acute pancreatitis with severe lactic acidosis in an HIV-infected patient on didanosine therapy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Stavudine: an update of its use in the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Stavudine selectively induces apoptosis in HIV type 1-infected cells

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

Hydroxyurea and HIV: 5 years later--from antiviral to immune-modulating effects

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)95004-3

7 January 2021

10.1016/S0149-2918(00)95004-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10929917 AND SRC:MED&resulttype=core&format=json

9 November 2019

1 reference